Isabel Chirivella
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 25
- Colorectal Cancer Treatments and Studies 8
- Cancer Treatment and Pharmacology 7
- Cancer-related Molecular Pathways 5
-
- DNA Repair Mechanisms 6
- Co-authors
- Andrés Cervantes (9 shared papers)Arié Figer (6 shared papers)Thierry André (6 shared papers)M. Flesch (6 shared papers)Gérard Lledo (6 shared papers)Élisabeth Carola (4 shared papers)Fernando Rivera (3 shared papers)Christophe Tournigand (4 shared papers)
- Journals
- Journal of Clinical Oncology (12 papers)Clinical & Translational Oncology (9 papers)Annals of Oncology (3 papers)Breast Cancer Research and Treatment (3 papers)Cancers (2 papers)
- Partner nations
- SpainFranceUnited States
In The Last Decade
Isabel Chirivella
49 papers receiving 1.5k citations
Isabel Chirivella's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 964
- Hepatology 165
- Cancer Research 197
- Pulmonary and Respiratory Medicine 298
- Pathology and Forensic Medicine 116
Countries citing papers authored by Isabel Chirivella
This map shows the geographic impact of Isabel Chirivella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Chirivella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Chirivella more than expected).
Fields of papers citing papers by Isabel Chirivella
This network shows the impact of papers produced by Isabel Chirivella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Chirivella. The network helps show where Isabel Chirivella may publish in the future.
Co-authors
The 25 scholars most cited alongside Isabel Chirivella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study Hit paper breakdown → | 2006 | 607 |
| 2 | 2008 | 144 | |
| 3 | 2007 | 105 | |
| 4 | 2010 | 96 | |
| 5 | 2015 | 84 | |
| 6 | 2009 | 53 | |
| 7 | 2008 | 50 | |
| 8 | 2011 | 40 | |
| 9 | 2003 | 31 | |
| 10 | 2014 | 26 | |
| 11 | Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine. | 2015 | 25 |
| 12 | 2018 | 20 | |
| 13 | 2020 | 19 | |
| 14 | 2007 | 18 | |
| 15 | Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer. | 2015 | 18 |
| 16 | 2021 | 17 | |
| 17 | 2007 | 17 | |
| 18 | 2006 | 16 | |
| 19 | 2020 | 15 | |
| 20 | 2014 | 15 |
About Isabel Chirivella
Isabel Chirivella is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 53 papers that have together received 1.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), BRCA gene mutations in cancer (7 papers), Cancer Treatment and Pharmacology (7 papers), DNA Repair Mechanisms (6 papers), Renal cell carcinoma treatment (5 papers), Cancer Genomics and Diagnostics (5 papers), Cancer-related Molecular Pathways (5 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Oncology (964 citations), Hepatology (165 citations), Cancer Research (197 citations), Pulmonary and Respiratory Medicine (298 citations) and Pathology and Forensic Medicine (116 citations). Isabel Chirivella has collaborated with scholars based in Spain, France and United States. Frequent co-authors include Andrés Cervantes, Arié Figer, Thierry André, M. Flesch, Gérard Lledo, Élisabeth Carola, Fernando Rivera, Christophe Tournigand, Christophe Louvet and Pierre-Luc Etienne. Their work appears in journals such as Journal of Clinical Oncology, Clinical & Translational Oncology, Annals of Oncology, Breast Cancer Research and Treatment and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.